Hypertension management in the elderly and the very elderly

Area of Science:

• Gerontology
• Cardiology
• Pharmacology

Background:

• Hypertension prevalence significantly increases with age, posing a major risk for cardiovascular diseases like stroke and coronary artery disease in older adults.
• Aging is linked to frailty, multimorbidity, and polypharmacy, complicating hypertension management and increasing vulnerability to adverse drug effects.
• Specific conditions such as diabetes, Parkinson disease, and aortic stenosis present unique challenges, including orthostatic hypotension risk and hemodynamic instability.

Purpose of the Study:

• To highlight the complexities of managing hypertension in the elderly population.
• To emphasize the need for individualized risk-benefit assessments for antihypertensive therapy in older patients.
• To underscore the importance of considering comorbidities and polypharmacy in treatment strategies.

Main Methods:

• Review of existing literature on hypertension in aging populations.
• Analysis of age-related physiological changes and their impact on cardiovascular health.
• Examination of drug interactions and side effects of antihypertensive medications in older adults.

Main Results:

• Older adults face a higher risk of stroke and coronary artery disease due to hypertension.
• Frailty, multimorbidity, and polypharmacy significantly complicate treatment decisions.
• Adverse effects from antihypertensive drugs, including orthostatic hypotension, are more pronounced in this demographic.
• Target-organ damage can result from both uncontrolled hypertension and its treatment.

Conclusions:

• A personalized approach is essential for managing hypertension in older adults.
• Careful risk-benefit assessment and consideration of individual patient profiles are necessary for selecting appropriate blood pressure targets and treatments.
• Mitigating adverse drug effects and managing comorbidities are critical for optimizing outcomes.